F Fahimipour1, M Rasoulianboroujeni1, E Dashtimoghadam1, K Khoshroo1, M Tahriri1, F Bastami2, D Lobner3, L Tayebi4. 1. Marquette University School of Dentistry, Milwaukee, WI 53233, USA. 2. Research Institute of Dental Sciences, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 3. Department of Biomedical Sciences, Marquette University, Milwaukee, WI 53233, USA. 4. Marquette University School of Dentistry, Milwaukee, WI 53233, USA; Department of Engineering Science, University of Oxford, Oxford OX1 3PJ, UK. Electronic address: lobat.tayebi@marquette.edu.
Abstract
OBJECTIVE: Vascularization is a critical process during bone regeneration/repair and the lack of tissue vascularization is recognized as a major challenge in applying bone tissue engineering methods for cranial and maxillofacial surgeries. The aim of our study is to fabricate a vascular endothelial growth factor (VEGF)-loaded gelatin/alginate/β-TCP composite scaffold by 3D printing method using a computer-assisted design (CAD) model. METHODS: The paste, composed of (VEGF-loaded PLGA)-containing gelatin/alginate/β-TCP in water, was loaded into standard Nordson cartridges and promptly employed for printing the scaffolds. Rheological characterization of various gelatin/alginate/β-TCP formulations led to an optimized paste as a printable bioink at room temperature. RESULTS: The in vitro release kinetics of the loaded VEGF revealed that the designed scaffolds fulfill the bioavailability of VEGF required for vascularization in the early stages of tissue regeneration. The results were confirmed by two times increment of proliferation of human umbilical vein endothelial cells (HUVECs) seeded on the scaffolds after 10 days. The compressive modulus of the scaffolds, 98±11MPa, was found to be in the range of cancellous bone suggesting their potential application for craniofacial tissue engineering. Osteoblast culture on the scaffolds showed that the construct supports cell viability, adhesion and proliferation. It was found that the ALP activity increased over 50% using VEGF-loaded scaffolds after 2 weeks of culture. SIGNIFICANCE: The 3D printed gelatin/alginate/β-TCP scaffold with slow releasing of VEGF can be considered as a potential candidate for regeneration of craniofacial defects.
OBJECTIVE: Vascularization is a critical process during bone regeneration/repair and the lack of tissue vascularization is recognized as a major challenge in applying bone tissue engineering methods for cranial and maxillofacial surgeries. The aim of our study is to fabricate a vascular endothelial growth factor (VEGF)-loaded gelatin/alginate/β-TCP composite scaffold by 3D printing method using a computer-assisted design (CAD) model. METHODS: The paste, composed of (VEGF-loaded PLGA)-containing gelatin/alginate/β-TCP in water, was loaded into standard Nordson cartridges and promptly employed for printing the scaffolds. Rheological characterization of various gelatin/alginate/β-TCP formulations led to an optimized paste as a printable bioink at room temperature. RESULTS: The in vitro release kinetics of the loaded VEGF revealed that the designed scaffolds fulfill the bioavailability of VEGF required for vascularization in the early stages of tissue regeneration. The results were confirmed by two times increment of proliferation of human umbilical vein endothelial cells (HUVECs) seeded on the scaffolds after 10 days. The compressive modulus of the scaffolds, 98±11MPa, was found to be in the range of cancellous bone suggesting their potential application for craniofacial tissue engineering. Osteoblast culture on the scaffolds showed that the construct supports cell viability, adhesion and proliferation. It was found that the ALP activity increased over 50% using VEGF-loaded scaffolds after 2 weeks of culture. SIGNIFICANCE: The 3D printed gelatin/alginate/β-TCP scaffold with slow releasing of VEGF can be considered as a potential candidate for regeneration of craniofacial defects.
Authors: Hossein E Jazayeri; Mohammadreza Tahriri; Mehdi Razavi; Kimia Khoshroo; Farahnaz Fahimipour; Erfan Dashtimoghadam; Luis Almeida; Lobat Tayebi Journal: Mater Sci Eng C Mater Biol Appl Date: 2016-08-24 Impact factor: 7.328
Authors: Julia Schnieders; Uwe Gbureck; Elke Vorndran; Michael Schossig; Thomas Kissel Journal: J Biomed Mater Res B Appl Biomater Date: 2011-09-21 Impact factor: 3.368
Authors: Sophie C Cox; John A Thornby; Gregory J Gibbons; Mark A Williams; Kajal K Mallick Journal: Mater Sci Eng C Mater Biol Appl Date: 2014-11-08 Impact factor: 7.328
Authors: Zeynep Aytac; Nileshkumar Dubey; Arwa Daghrery; Jessica A Ferreira; Isaac J de Souza Araújo; Miguel Castilho; Jos Malda; Marco C Bottino Journal: Int Mater Rev Date: 2021-07-05 Impact factor: 15.750
Authors: Yoontae Kim; Eun-Jin Lee; Albert V Davydov; Stanislav Frukhtbeyen; Jonathan E Seppala; Shozo Takagi; Laurence Chow; Stella Alimperti Journal: Biomed Mater Date: 2021-03-08 Impact factor: 3.715
Authors: Sean M Bittner; Hannah A Pearce; Katie J Hogan; Mollie M Smoak; Jason L Guo; Anthony J Melchiorri; David W Scott; Antonios G Mikos Journal: Tissue Eng Part A Date: 2021-02-24 Impact factor: 4.080